Skip to main content

Table 2 The correlation coefficients between plasma sclerostin concentrations and the serum concentrations of: calcium, phosphate, PTH, and the dose of cinacalcet

From: Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism

 

Plasma sclerostin [ng/ml]

baseline

3 months

6 months

serum calcium [mmol/l]

baseline

R = -0.06; p = 0.67

  

3 months

 

R = -0.06; p = 0.67

 

6 months

  

R = 0.19; p = 0.18

serum phosphate [mmol/l]

baseline

R = 0.43; p = 0.001

  

3 months

 

R = 0.24; p = 0.08

 

6 months

  

R = -0.34; p = 0.01

serum PTH [ng/ml]

baseline

R = -0.27; p = 0.046

  

3 months

 

R = -0.25; p = 0.07

 

6 months

  

R = -0.40; p = 0.003

cinacalcet dose [mg]

baseline

n/a

  

3 months

 

R = 0.05; p = 0.72

 

6 months

  

R = -0.03; p = 0.84

  1. PTH parathyroid hormone